News

Robert Blaustein, M.D., Ph.D., joins the Company as Chief Development Officer, responsible for leading EDG-7500, a novel cardiac sarcomere modulator in Phase 2 development, ...
The company also announced the appointment of Robert Blaustein, M.D., Ph.D., as Chief Development Officer, who will lead the development of EDG-7500, a novel cardiac sarcomere modulator currently ...
Kevin Koch, the President and CEO of Edgewise Therapeutics , Inc. (NASDAQ:EWTX), a biotechnology company with a market capitalization of $2.5 billion, recently executed a series of stock ...
Edgewise Therapeutics (EWTX) announced changes to its executive team. These changes include the addition of Robert Blaustein, joining the company as chief development officer and the promotion of ...
Claire Marie Blaustein and Roberto Seamus Peña were married May 25 at St. Aloysius Church at Gonzaga College High School in Washington. The Rev. Gasper LoBiondo, a Roman Catholic priest ...
„Wir wollen Blaustein und den Alb-Donau-Kreis weiterhin konstruktiv gestalten und die Zukunftsthemen vorantreiben“, leitete Kreis- und Stadtrat Robert Jungwirth die Begrüßung ein.
Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced key changes to its executive team that will strengthen its leadership and sharpen the ...
Ann & Robert H. Lurie Children’s Hospital of Chicago announced the appointment of Ron Blaustein, 43, as Chief Financial Officer, effective June 1, 2014. Mr. Blaustein succeeds Paula Noble, who ...
Robert Blaustein, M.D., Ph.D., Chief Development Officer, Edgewise Therapeutics. "These leadership changes signify our... Edgewise Therapeutics Strengthens Leadership Team to Support Late-Stage ...
Robert Blaustein, M.D., Ph.D., joins the Company as Chief Development Officer, responsible for leading EDG-7500, a novel cardiac sarcomere modulator in Phase 2 development, ...
BOULDER, Colo., January 22, 2025--Edgewise Therapeutics, Inc., (Nasdaq: EWTX), a leading muscle disease biopharmaceutical company, today announced key changes to its executive team that will ...